Nucleic Acid Labeling Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The market is segmented By Label Type (Biotin-based, Fluorescent, Radioactive, and Other Label Types), Application, End-User, and Geography

Nucleic Acid Labeling Market Size

Compare market size and growth of Nucleic Acid Labeling Market with other markets in Healthcare Industry

Nucleic Acid Labeling Market Analysis

The Nucleic Acid Labeling Market is expected to register a CAGR of 7.5% during the forecast period.

Personalized medicine aims to provide tailor-made therapies to individual patients, depending on the molecular basis of disease, which has become popular in recent years. Healthcare technology, genomics involving nucleic acid labeling technology, connected devices, big data analytics, and artificial intelligence are generating vast amounts of health data and insights. This is enabling healthcare providers to offer better and faster diagnoses and make more informed treatment decisions. Rising demand for personalized medicine has created tremendous opportunities in the field of genetic medicine, and in order to exploit these opportunities, novel technologies must be developed, which, in turn, has resulted in the rapid expansion of the market. Therefore, increasing focus on personalized medicine and patient-centered approach is driving the growth of the nucleic acid labeling market.

Nucleic Acid Labeling Industry Overview

The global players into the nucleic acid labeling market are Enzo Biochem Inc., GE Healthcare, Marker Gene Technologies Inc., Merck KGaA, New England Biolabs Inc., PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific and Vector Laboratories Inc.

Nucleic Acid Labeling Market Leaders

  1. GE Healthcare

  2. Merck KGaA

  3. PerkinElmer Inc.

  4. Promega Corporation

  5. Thermo Fisher Scientific

  6. *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF

Nucleic Acid Labeling Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Genomic and Enzymology Research
    • 4.2.2 Advancements in Tools for Synthetic Genome Design
    • 4.2.3 Growing Demand for Personalized Medicine
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
    • 4.3.2 High Cost and Complexity of Techniques
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Label Type
    • 5.1.1 Biotin-based
    • 5.1.2 Fluorescent
    • 5.1.3 Radioactive
    • 5.1.4 Other Label Types
  • 5.2 By Application
    • 5.2.1 Microarray
    • 5.2.2 DNA Sequencing
    • 5.2.3 In situ Hybridization
    • 5.2.4 Polymerase Chain Reaction
    • 5.2.5 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals/Clinics
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Enzo Biochem Inc.
    • 6.1.2 GE Healthcare
    • 6.1.3 Marker Gene Technologies Inc.
    • 6.1.4 Merck KGaA
    • 6.1.5 New England Biolabs Inc.
    • 6.1.6 PerkinElmer Inc.
    • 6.1.7 Promega Corporation
    • 6.1.8 Thermo Fisher Scientific
    • 6.1.9 Vector Laboratories Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Nucleic Acid Labeling Industry Segmentation

As per the scope of the report, nucleic acids are complex biomolecules that are responsible for the transfer of genetic information in all living organisms. Nucleic acid labeling is a procedure in which nucleic acids are modified or attached with tags that enable their detection or purification.

By Label Type Biotin-based
Fluorescent
Radioactive
Other Label Types
By Application Microarray
DNA Sequencing
In situ Hybridization
Polymerase Chain Reaction
Other Applications
By End User Hospitals/Clinics
Diagnostic Centers
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Nucleic Acid Labeling Market Research FAQs

What is the current Nucleic Acid Labeling Market size?

The Nucleic Acid Labeling Market is projected to register a CAGR of 7.5% during the forecast period (2025-2030)

Who are the key players in Nucleic Acid Labeling Market?

GE Healthcare, Merck KGaA, PerkinElmer Inc., Promega Corporation and Thermo Fisher Scientific are the major companies operating in the Nucleic Acid Labeling Market.

Which is the fastest growing region in Nucleic Acid Labeling Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Nucleic Acid Labeling Market?

In 2025, the North America accounts for the largest market share in Nucleic Acid Labeling Market.

What years does this Nucleic Acid Labeling Market cover?

The report covers the Nucleic Acid Labeling Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Nucleic Acid Labeling Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Nucleic Acid Labeling Industry Report

Statistics for the 2025 Nucleic Acid Labeling market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Nucleic Acid Labeling analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Nucleic Acid Labeling Report Snapshots

Nucleic Acid Labeling Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)